Caxton Associates (UK)’s Celestica CLS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$704K Sell
2,500
-5,200
-68% -$1.51M 0.02% 449
2025
Q4
$2.28M Sell
7,700
-4,491
-37% -$1.35M 0.04% 166
2025
Q3
$3M Buy
+12,191
New +$2.46M 0.07% 129
2025
Q2
Sell
-36,000
Closed -$2.84M 713
2025
Q1
$2.84M Buy
+36,000
New +$3.82M 0.1% 99

Other funds holding CLS

Caxton Associates (UK)'s CLS Position: Q1 2026 in Review

Caxton Associates (UK) reduced its Celestica (CLS) stake by 68% in Q1 2026, selling an estimated $1.51M and leaving 2,500 shares worth $704K. The position accounts for 0.02% of the portfolio, ranked #449.

Caxton Associates (UK) first reported a position in CLS in Q1 2025 and has held it in 4 quarters since. The position peaked at $3M in Q3 2025. 773 funds tracked by Wall St. Rank hold CLS as of Q1 2026.

  • Caxton Associates (UK) held 2,500 shares of Celestica worth $704K as of Q1 2026.
  • Caxton Associates (UK) sold 5,200 Celestica shares in Q1 2026, an estimated $1.51M.
  • Celestica made up 0.02% of Caxton Associates (UK)'s portfolio in Q1 2026, its #449 holding.
  • Caxton Associates (UK) first reported a position in Celestica in Q1 2025 and has held it in 4 quarters since.
  • Caxton Associates (UK)'s Celestica position peaked at $3M in Q3 2025.
  • 773 funds tracked by Wall St. Rank held Celestica as of Q1 2026.

Based on Caxton Associates (UK)'s 13F filing for Q1 2026, filed 14 May 2026.